{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:25:36Z","timestamp":1792200336666,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jpsychires.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T12:08:46Z","timestamp":1596110926000},"page":"280-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Can \u2018floating\u2019 predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression"],"prefix":"10.1016","volume":"130","author":[{"given":"Elia E.","family":"Acevedo-Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace W.","family":"Cavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Greenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2020.06.012_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jad.2019.11.028","article-title":"Comprehensive assesment of side effects associated with a single dose of ketamine in treatment-resistant depression","volume":"263","author":"Acevedo-Diaz","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2015.1072653","article-title":"Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction","volume":"47","author":"Bonnet","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the clinician-administered dissociative States scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma Stress"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2044.1972.tb08186.x","article-title":"Ketamine and the conscious mind","volume":"27","author":"Collier","year":"1972","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"Diazgranados","year":"2010","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola","year":"2015","journal-title":"Ther. Adv. Chron. Dis."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2017.11.088","article-title":"Dissociation after ketamine dosing: is the CADSS fit for purpose?","volume":"244","author":"Neehoff","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2018.02.049","article-title":"Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression","volume":"232","author":"Niciu","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","article-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs","volume":"244","author":"Olney","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/da.22536","article-title":"A review of ketamine abuse and diversion","volume":"33","author":"Sassano-Higgins","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000497441","article-title":"The altered-state-of-consciousness aspect of a feeling of lightness is reported to be associated with antidepressant benefits by depressed individuals receiving ketamine infusions: a systematic analysis of internet video testimonials","volume":"88","author":"Stocker","year":"2019","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajem.2007.12.005","article-title":"Adverse events associated with ketamine for procedural sedation in adults","volume":"26","author":"Strayer","year":"2008","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2017.09.023","article-title":"Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: analysis of the Clinician Administered Dissociative State Scale","volume":"227","author":"van Schalkwyk","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib20","doi-asserted-by":"crossref","first-page":"17m11731","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/appi.ajp.2017.17020239","article-title":"A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders","volume":"174","author":"Wilkinson","year":"2017","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jpsychires.2020.06.012_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.06.012_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562030844X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239562030844X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:19:54Z","timestamp":1758367194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239562030844X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":25,"alternative-id":["S002239562030844X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.06.012","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can \u2018floating\u2019 predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}